How would you approach a locally advanced NSCLC s/p pneumonectomy now with multi-station mediastinal nodal recurrence?
What would be your dose/fractionation, contouring/margins, dose constraints for the remaining/contralateral lung?
1 Answer
Mednet Member
Radiation Oncology · Tennessee Oncology
Answered on
Very tough clinical scenario. I routinely say that in an era where we have good options with both peri-op chemoimmunotherapy or chemoradiation followed by immunotherapy, patients with LA-NSCLC shouldn't be getting pneumonectomies (with rare exceptions). Stepping off that soapbox, I'd start with a go...
Join for free or sign in to see the full answer